Oppenheimer Maintains Outperform on Amgen, Raises Price Target to $480
Benzinga Newsdesk 1 week ago
Analyst RatingsNewsPrice TargetHot
Oppenheimer analyst Jay Olson maintains Amgen (NASDAQ:AMGN) with a Outperform and raises the price target from $450 to $480.
Oppenheimer analyst Jay Olson maintains Amgen (NASDAQ:AMGN) with a Outperform and raises the price target from $450 to $480.